Display options
Cite
Scurlock HJ, Singh AN, Catalan J. Atypical antipsychotic drugs in the treatment of manic syndromes in patients with HIV-1 infection. J Psychopharmacol. 1995;9(2):151-4doi: 10.1177/026988119500900210.
Scurlock, H. J., Singh, A. N., & Catalan, J. (1995). Atypical antipsychotic drugs in the treatment of manic syndromes in patients with HIV-1 infection. Journal of psychopharmacology (Oxford, England), 9(2), 151-4. https://doi.org/10.1177/026988119500900210
Scurlock, H J, et al. "Atypical antipsychotic drugs in the treatment of manic syndromes in patients with HIV-1 infection." Journal of psychopharmacology (Oxford, England) vol. 9,2 (1995): 151-4. doi: https://doi.org/10.1177/026988119500900210
Scurlock HJ, Singh AN, Catalan J. Atypical antipsychotic drugs in the treatment of manic syndromes in patients with HIV-1 infection. J Psychopharmacol. 1995 Jan;9(2):151-4. doi: 10.1177/026988119500900210. PMID: 22298741.
Copy Download .nbib Format: NLM
Share it on

J Psychopharmacol. 1995 Jan;9(2):151-4. doi: 10.1177/026988119500900210.

Atypical antipsychotic drugs in the treatment of manic syndromes in patients with HIV-1 infection.

Journal of psychopharmacology (Oxford, England)

H J Scurlock, A N Singh, J Catalan

Affiliations

  1. Psychological Medicine Unit, Charing Cross and Westminster Medical School and Mental Health Centre, Chelsea and Westminster Hospital 369 Fulham Road, London SW10 9NG, UK.

PMID: 22298741 DOI: 10.1177/026988119500900210

Abstract

We report four people with human immunodeficiency virus (HIV) infection and mania whose manic symptoms improved when given the atypical antipsychotic agent remoxipride as an adjunct, and in whom traditional neuroleptics were not well tolerated due to marked extrapyramidal side effects. General issues surrounding choice of pharmacological agent in HIV-related mania are discussed.

Publication Types